Literature DB >> 31020264

Pulmonary vein perforation into bronchi: a rare but life-threatening complication of cryoballoon ablation.

Hiroshi Fukunaga1, Ryosuke Higuchi1, Kohei Tanizaki1, Mitsuaki Isobe1.   

Abstract

Entities:  

Year:  2019        PMID: 31020264      PMCID: PMC6439370          DOI: 10.1093/ehjcr/ytz022

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


× No keyword cloud information.
Cryoballoon ablation (CBA) has been widely accepted as a treatment of paroxysmal atrial fibrillation (PAF), however, serious procedural complications can occur, including oesophageal ulcer, atrio-oesophageal fistula, bronchial injury, and phrenic nerve injury. A 71-year-old man with PAF underwent catheter ablation using the CBA system. Cryoballoon ablation was performed under conscious sedation going on dabigatran 220 mg (pre-procedural activated partial thromboplastin time: 28.6 s). A circular mapping catheter (a 20-mm Achieve, Medtronic, Minneapolis, MN, USA) and a cryoballoon catheter (a 28-mm Arctic Front Advance, Medtronic) were advanced into the left atrium via a steerable sheath. First, we targeted the left superior pulmonary vein (LSPV). A circular mapping catheter was advanced in the superior branch of the LSPV, and a cryoballoon catheter was positioned at the antrum of the LSPV. Following the first application to the LSPV, the patient developed nose bleeding, and his blood pressure gradually dropped. The venography of the LSPV revealed bleeding from the small branch of the LSPV, perforating into the bronchi (Figure –D; Supplementary material online, Video S1). We intubated the patient to protect his airway (Figure ), and neutralized the anticoagulants using idarucizumab and protamine sulfate. We confirmed haemostasis of the perforated pulmonary vein. The patient recovered from a complicated chemical pneumonitis (Figure ) and was discharged without a sequela. (A, B) Perforation of left superior pulmonary vein into bronchi (white arrowheads: extravasation from pulmonary vein; yellow arrowhead: the tip of cryoballoon catheter; and blue arrowhead: the tip of mapping catheter). (C) Computed tomography image of pulmonary vein (blue arrowhead: left superior pulmonary vein). (D) Pulmonary haemorrhage caused by pulmonary vein perforation. (E) Haemorrhage in left upper branch on bronchoscopy. (F) Post-procedural chemical pneumonitis. Similar to the transcatheter closure of atrial septal defects and transcatheter mitral valve repair, stiff guidewires, or catheters can injure the pulmonary vein in CBA. A bronchial injury could occur during or after CBA especially in case of low nadir balloon temperature., In our case, the stiff part of the mapping catheter probably damaged the LSPV, which had not previously been reported. Adequate countertraction of a mapping catheter is necessary when a cryoballoon catheter is advanced. Careful handling of the guidewires and catheters is important during CBA, and a specific neutralizing anticoagulant is essential to control bleeding complications. Click here for additional data file.
  4 in total

1.  Successful removal of a circular mapping catheter which perforated the pulmonary vein during cryoballoon ablation by lateral thoracotomy: a case report.

Authors:  Reisuke Yoshizawa; Shingen Owada; Yohei Sawa; Hiroyuki Deguchi
Journal:  Eur Heart J Case Rep       Date:  2020-07-06

2.  Pulmonary Vein Perforation and Life-Threatening Hemoptysis During Cryoballoon Ablation for Persistent Atrial Fibrillation.

Authors:  Koji Sudo; Takatoshi Shigeta; Atsuhito Oda; Shinichi Tachibana; Yuichiro Sagawa; Rena Nakamura; Kaoru Okishige; Yasuteru Yamauchi
Journal:  JACC Case Rep       Date:  2022-04-06

3.  Hemothorax as an Occult Cause of Hypotension After Transseptal Puncture.

Authors:  Arthur Iturriagagoitia; Xavier Iturriagagoitia
Journal:  Am J Case Rep       Date:  2022-05-09

4.  Comparison of the Efficacy and Safety Endpoints of Five Therapies for Atrial Fibrillation: A Network Meta-Analysis.

Authors:  Tongyu Wang; Tingting Fang; Zeyi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.